These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 29158552)
1. Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray. Hayeems RZ; Bhawra J; Tsiplova K; Meyn MS; Monfared N; Bowdin S; Stavropoulos DJ; Marshall CR; Basran R; Shuman C; Ito S; Cohn I; Hum C; Girdea M; Brudno M; Cohn RD; Scherer SW; Ungar WJ Eur J Hum Genet; 2017 Dec; 25(12):1303-1312. PubMed ID: 29158552 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder. Yuen T; Carter MT; Szatmari P; Ungar WJ Appl Health Econ Health Policy; 2018 Aug; 16(4):481-493. PubMed ID: 29651777 [TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders. Runheim H; Pettersson M; Hammarsjö A; Nordgren A; Henriksson M; Lindstrand A; Levin LÅ; Soller MJ Sci Rep; 2023 Apr; 13(1):6904. PubMed ID: 37106068 [TBL] [Abstract][Full Text] [Related]
4. Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing. Pasmans CTB; Tops BBJ; Steeghs EMP; Coupé VMH; Grünberg K; de Jong EK; Schuuring EMD; Willems SM; Ligtenberg MJL; Retèl VP; van Snellenberg H; de Bruijn E; Cuppen E; Frederix GWJ Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):413-414. PubMed ID: 33852815 [No Abstract] [Full Text] [Related]
5. A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder. Tsiplova K; Zur RM; Marshall CR; Stavropoulos DJ; Pereira SL; Merico D; Young EJ; Sung WWL; Scherer SW; Ungar WJ Genet Med; 2017 Nov; 19(11):1268-1275. PubMed ID: 28471434 [TBL] [Abstract][Full Text] [Related]
6. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability. Lindstrand A; Eisfeldt J; Pettersson M; Carvalho CMB; Kvarnung M; Grigelioniene G; Anderlid BM; Bjerin O; Gustavsson P; Hammarsjö A; Georgii-Hemming P; Iwarsson E; Johansson-Soller M; Lagerstedt-Robinson K; Lieden A; Magnusson M; Martin M; Malmgren H; Nordenskjöld M; Norling A; Sahlin E; Stranneheim H; Tham E; Wincent J; Ygberg S; Wedell A; Wirta V; Nordgren A; Lundin J; Nilsson D Genome Med; 2019 Nov; 11(1):68. PubMed ID: 31694722 [TBL] [Abstract][Full Text] [Related]
7. Whole Genome Sequencing in the Evaluation of Fetal Structural Anomalies: A Parallel Test with Chromosomal Microarray Plus Whole Exome Sequencing. Zhou J; Yang Z; Sun J; Liu L; Zhou X; Liu F; Xing Y; Cui S; Xiong S; Liu X; Yang Y; Wei X; Zou G; Wang Z; Wei X; Wang Y; Zhang Y; Yan S; Wu F; Zeng F; Wang J; Duan T; Peng Z; Sun L Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33800913 [TBL] [Abstract][Full Text] [Related]
8. Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial. Christensen KD; Vassy JL; Phillips KA; Blout CL; Azzariti DR; Lu CY; Robinson JO; Lee K; Douglas MP; Yeh JM; Machini K; Stout NK; Rehm HL; McGuire AL; Green RC; Dukhovny D; Genet Med; 2018 Dec; 20(12):1544-1553. PubMed ID: 29565423 [TBL] [Abstract][Full Text] [Related]
9. Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence. Nurchis MC; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Tartaglia M; Cicchetti A; Dallapiccola B; Damiani G Health Policy; 2022 Apr; 126(4):337-345. PubMed ID: 35317923 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. Clark MM; Stark Z; Farnaes L; Tan TY; White SM; Dimmock D; Kingsmore SF NPJ Genom Med; 2018; 3():16. PubMed ID: 30002876 [TBL] [Abstract][Full Text] [Related]
12. Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarray. Hayeems RZ; Hoang N; Chenier S; Stavropoulos DJ; Pu S; Weksberg R; Shuman C Eur J Hum Genet; 2015 Sep; 23(9):1135-41. PubMed ID: 25491637 [TBL] [Abstract][Full Text] [Related]
13. A survey of undetected, clinically relevant chromosome abnormalities when replacing postnatal karyotyping by Whole Genome Sequencing. Hochstenbach R; van Binsbergen E; Schuring-Blom H; Buijs A; Ploos van Amstel HK Eur J Med Genet; 2019 Sep; 62(9):103543. PubMed ID: 30248410 [TBL] [Abstract][Full Text] [Related]